Covid-19 severe hypoxemic pneumonia: A clinical experience using high-flow nasal oxygen therapy as first-line management

PURPOSE: To report a French experience in patients admitted to Intensive Care Unit (ICU) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requiring high fractional concentration of inspired oxygen supported by high flow nasal cannula (HFNC) as first-line therapy. METHODS: Retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Beduneau, G., Boyer, D., Guitard, P.-G., Gouin, P., Carpentier, D., Grangé, S., Veber, B., Girault, C., Tamion, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Masson SAS. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175099/
https://www.ncbi.nlm.nih.gov/pubmed/34153702
http://dx.doi.org/10.1016/j.resmer.2021.100834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175099/
https://www.ncbi.nlm.nih.gov/pubmed/34153702
http://dx.doi.org/10.1016/j.resmer.2021.100834

Ejemplares similares